A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation

Summary

The objective of this study is to evaluate multiple doses of BLI801 Laxative for safety and efficacy versus placebo in adults experiencing non-idiopathic constipation.

Timeline

Start

2016-06

Primary completion

2017-04

Completion

2017-04

Outcome

Met primary endpoint

registry analysis (superiority test); BLI801 Laxative (High Dose) vs BLI801 Laxative (Mid Dose) vs BLI801 Laxative (Low Dose) vs BLI801 Placebo; p = 0.034; Cochran-Mantel-Haenszel NCT02822508 ↗

Drugs

Indications